A four-season molecule: osteocalcin. Updates in its physiological roles

Endocrine

Volumn 48, Issue 2, 2015, Pages 394-404

  Lombardi, Giovanni ^a   Perego, Silvia ^a   Luzi, Livio ^b,c   Banfi, Giuseppe ^a,b  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Bone turnover; Ectopic calcification; Energy metabolism; Fertility; Muscle strength; Glutamyl transferases

Indexed keywords

ALENDRONIC ACID; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 4; ETIDRONIC ACID; GAMMA GLUTAMYLTRANSFERASE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MENADIONE; MENAQUINONE; OSTEOCALCIN; PARATHYROID HORMONE; PHYTOMENADIONE; RALOXIFENE; SEX HORMONE; TESTOSTERONE; VITAMIN K GROUP;

ADIPOCYTE; AMINO ACID SEQUENCE; BLOOD VESSEL CALCIFICATION; BODY MASS; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; CALCIFICATION; CARBOXY TERMINAL SEQUENCE; CARBOXYLATION; CELL DIFFERENTIATION; CIRCADIAN RHYTHM; ENDOPLASMIC RETICULUM; ENERGY EXPENDITURE; ENERGY METABOLISM; EXTRACELLULAR MATRIX; FERTILITY; GLUCOSE METABOLISM; HUMAN; LEYDIG CELL; LIPID DIET; MUSCLE CONTRACTION; MUSCLE STRENGTH; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SOFT TISSUE CALCIFICATION; CHEMISTRY; METABOLISM; PHYSIOLOGY;

HUMANS; OSTEOCALCIN;

EID: 84942303210     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0401-0     Document Type: Review

References (132)

1. P.V. Hauschka, J.B. Lian, D.E. Cole, C.M. Gundberg, Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol. Rev. 69(3), 990–1047 (1989)
2. J.P. Brown, P.D. Delmas, L. Malaval, C. Edouard, M.C. Chapuy, P.J. Meunier, Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1(8386), 1091–1093 (1984)
3. G. Lombardi, P. Lanteri, A. Colombini, G. Banfi, Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling. Clin. Chem. Lab. Med. 50(5), 771–789 (2012)
4. C. Chenu, S. Colucci, M. Grano, P. Zigrino, R. Barattolo, G. Zambonin, N. Baldini, P. Vergnaud, P.D. Delmas, A.Z. Zallone, Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J. Cell Biol. 127(4), 1149–1158 (1994)
5. P.V. Bodine, B.S. Komm, Evidence that conditionally immortalized human osteoblasts express an osteocalcin receptor. Bone 25(5), 535–543 (1999)
6. M.S. Calvo, D.R. Eyre, C.M. Gundberg, Molecular basis and clinical application of biological markers of bone turnover. Endocr. Rev. 17(4), 333–368 (1996)
7. P.M. Kidd, Vitamins D and K as pleiotropic nutrients: clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy. Altern. Med. Rev. 15(3), 199–222 (2010)
8. S. Butenas, K.G. Mann, Blood coagulation. Biochemistry (Mosc) 67(1), 3–12 (2002)
9. N.K. Lee, H. Sowa, E. Hinoi, M. Ferron, J.D. Ahn, C. Confavreux, R. Dacquin, P.J. Mee, M.D. McKee, D.Y. Jung, Z. Zhang, J.K. Kim, F. Mauvais-Jarvis, P. Ducy, G. Karsenty, Endocrine regulation of energy metabolism by the skeleton. Cell 130(3), 456–469 (2007)
10. E. Puchacz, J.B. Lian, G.S. Stein, J. Wozney, K. Huebner, C. Croce, Chromosomal localization of the human osteocalcin gene. Endocrinology 124(5), 2648–2650 (1989)
11. L. Cancela, C.L. Hsieh, U. Francke, P.A. Price, Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene. J. Biol. Chem. 265(25), 15040–15048 (1990)
12. A.J. Lee, S. Hodges, R. Eastell, Measurement of osteocalcin. Ann. Clin. Biochem. 37(Pt 4), 432–446 (2000)
13. P.V. Hauschka, S.A. Carr, K. Biemann, Primary structure of monkey osteocalcin. Biochemistry 21(4), 638–642 (1982)
14. Q.Q. Hoang, F. Sicheri, A.J. Howard, D.S. Yang, Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 425(6961), 977–980 (2003)
15. C.M. Gundberg, M.E. Clough, The osteocalcin propeptide is not secreted in vivo or in vitro. J. Bone Miner. Res. 7(1), 73–80 (1992)
16. R. Houben, B.A. Soute, M.H. Knapen, C. Vermeer, Strategies for developing human osteocalcin standards: a critical evaluation. Scand. J. Clin. Lab. Invest. Suppl. 227, 100–104 (1997)
17. K.L. Berkner, Vitamin K-dependent carboxylation. Vitam. Horm. 78, 131–156 (2008)
18. R.A. Atkinson, J.S. Evans, P.V. Hauschka, B.A. Levine, R. Meats, J.T. Triffitt, A.S. Virdi, R.J. Williams, Conformational studies of osteocalcin in solution. Eur. J. Biochem. 232(2), 515–521 (1995)
19. 2+-binding protein of bone matrix. Haemostasis 16(3–4), 258–272 (1986)
20. P.V. Hauschka, S.A. Carr, Calcium-dependent alpha-helical structure in osteocalcin. Biochemistry 21(10), 2538–2547 (1982)
21. S.L. Booth, J.W. Suttie, Dietary intake and adequacy of vitamin K. J. Nutr. 128(5), 785–788 (1998)
22. M.J. Shearer, X. Fu, S.L. Booth, Vitamin K nutrition, metabolism, and requirements: current concepts and future research. Adv. Nutr. 3(2), 182–195 (2012)
23. S.L. Booth, Roles for vitamin K beyond coagulation. Annu. Rev. Nutr. 29, 89–110 (2009)
24. A. Barchowsky, K. Tabrizi, R.S. Kent, A.R. Whorton, Inhibition of prostaglandin synthesis after metabolism of menadione by cultured porcine endothelial cells. J. Clin. Invest. 83(4), 1153–1159 (1989)
25. J.W. Nieves, Osteoporosis: the role of micronutrients. Am. J. Clin. Nutr. 81(5), 1232S–1239S (2005)
26. J. Oldenburg, M. Marinova, C. Muller-Reible, M. Watzka, The vitamin K cycle. Vitam. Horm. 78, 35–62 (2008)
27. M. Igarashi, Y. Yogiashi, M. Mihara, I. Takada, H. Kitagawa, S. Kato, Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene. Mol. Cell. Biol. 27(22), 7947–7954 (2007)
28. T. Yokoyama, K. Miyazawa, M. Naito, J. Toyotake, T. Tauchi, M. Itoh, A. Yuo, Y. Hayashi, M.M. Georgescu, Y. Kondo, S. Kondo, K. Ohyashiki, Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy 4(5), 629–640 (2008)
29. T. Tsujioka, Y. Miura, T. Otsuki, Y. Nishimura, F. Hyodoh, H. Wada, T. Sugihara, The mechanisms of vitamin K2-induced apoptosis of myeloma cells. Haematologica 91(5), 613–619 (2006)
30. K. Nimptsch, S. Rohrmann, R. Kaaks, J. Linseisen, Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am. J. Clin. Nutr. 91(5), 1348–1358 (2010)
31. M.K. Shea, S.L. Booth, J.M. Massaro, P.F. Jacques, R.B. D’Agostino Sr, B. Dawson-Hughes, J.M. Ordovas, C.J. O’Donnell, S. Kathiresan, J.F. Keaney Jr, R.S. Vasan, E.J. Benjamin, Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am. J. Epidemiol. 167(3), 313–320 (2008)
32. M. Kaneki, T. Hosoi, Y. Ouchi, H. Orimo, Pleiotropic actions of vitamin K: protector of bone health and beyond? Nutrition 22(7–8), 845–852 (2006)
33. M.A. Rishavy, K.L. Berkner, Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K-dependent carboxylase. Adv. Nutr. 3(2), 135–148 (2012)
34. J. Stenflo, P. Fernlund, W. Egan, P. Roepstorff, Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc. Natl. Acad. Sci. USA 71(7), 2730–2733 (1974)
35. P.V. Hauschka, J.B. Lian, P.M. Gallop, Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc. Natl. Acad. Sci. USA 72(10), 3925–3929 (1975)
36. P.A. Price, A.A. Otsuka, J.W. Poser, J. Kristaponis, N. Raman, Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc. Natl. Acad. Sci. USA 73(5), 1447–1451 (1976)
37. S.L. Booth, A. Centi, S.R. Smith, C. Gundberg, The role of osteocalcin in human glucose metabolism: marker or mediator? Nat. Rev. Endocrinol. 9(1), 43–55 (2013)
38. J.C. McCann, B.N. Ames, Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am. J. Clin. Nutr. 90(4), 889–907 (2009)
39. M. Fusaro, G. Crepaldi, S. Maggi, A. D’Angelo, L. Calo, D. Miozzo, A. Fornasieri, M. Gallieni, Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapies. Curr. Vasc. Pharmacol. 9(6), 763–769 (2011)
40. P.A. Price, Gla-containing proteins of bone. Connect. Tissue Res. 21(1–4), 51–57 (1989)
41. P.V. Hauschka, F.H. Wians Jr, Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat. Rec. 224(2), 180–188 (1989)
42. P. Ducy, C. Desbois, B. Boyce, G. Pinero, B. Story, C. Dunstan, E. Smith, J. Bonadio, S. Goldstein, C. Gundberg, A. Bradley, G. Karsenty, Increased bone formation in osteocalcin-deficient mice. Nature 382(6590), 448–452 (1996)
43. A.L. Boskey, S. Gadaleta, C. Gundberg, S.B. Doty, P. Ducy, G. Karsenty, Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23(3), 187–196 (1998)
44. A. Poundarik, C. Gundberg, D. Vashishth, Non-collageneous proteins influence bone mineral size, shape and orientation: a SAXS study. J. Bone. Miner. Res. 26(S1), S1 (2011)
45. P. Fratzl, O. Paris, K. Klaushofer, W.J. Landis, Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering. J. Clin. Invest. 97(2), 396–402 (1996)
46. M. Murshed, T. Schinke, M.D. McKee, G. Karsenty, Extracellular matrix mineralization is regulated locally; different roles of two Gla-containing proteins. J. Cell Biol. 165(5), 625–630 (2004)
47. J. Glowacki, J.B. Lian, Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants. Cell. Differ. 21(4), 247–254 (1987)
48. G. Karsenty, M. Ferron, The contribution of bone to whole-organism physiology. Nature 481(7381), 314–320 (2012)
49. C.B. Confavreux, Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney Int. Suppl. 121, S14–S19 (2011)
50. P.A. Price, J.W. Lothringer, S.A. Baukol, A.H. Reddi, Developmental appearance of the vitamin K-dependent protein of bone during calcification. Analysis of mineralizing tissues in human, calf, and rat. J. Biol. Chem. 256(8), 3781–3784 (1981)
51. M.J. Seibel, Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos. Int. 11(Suppl. 6), S18–S29 (2000)
52. L.J. Sokoll, S.L. Booth, K.W. Davidson, G.E. Dallal, J.A. Sadowski, Diurnal variation in total and undercarboxylated osteocalcin: influence of increased dietary phylloquinone. Calcif. Tissue Int. 62(5), 447–452 (1998)
53. S.J. Hodges, K. Akesson, P. Vergnaud, K. Obrant, P.D. Delmas, Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J. Bone Miner. Res. 8(10), 1241–1245 (1993)
54. S.J. Hodges, M.J. Pilkington, T.C. Stamp, A. Catterall, M.J. Shearer, L. Bitensky, J. Chayen, Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 12(6), 387–389 (1991)
55. S.L. Booth, K.L. Tucker, H. Chen, M.T. Hannan, D.R. Gagnon, L.A. Cupples, P.W. Wilson, J. Ordovas, E.J. Schaefer, B. Dawson-Hughes, D.P. Kiel, Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am. J. Clin. Nutr. 71(5), 1201–1208 (2000)
56. S.L. Booth, A.H. Lichtenstein, M. O’Brien-Morse, N.M. McKeown, R.J. Wood, E. Saltzman, C.M. Gundberg, Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am. J. Clin. Nutr. 74(6), 783–790 (2001)
57. S.L. Booth, K.E. Broe, D.R. Gagnon, K.L. Tucker, M.T. Hannan, R.R. McLean, B. Dawson-Hughes, P.W. Wilson, L.A. Cupples, D.P. Kiel, Vitamin K intake and bone mineral density in women and men. Am. J. Clin. Nutr. 77(2), 512–516 (2003)
58. M. Kaneki, S.J. Hodges, T. Hosoi, S. Fujiwara, A. Lyons, S.J. Crean, N. Ishida, M. Nakagawa, M. Takechi, Y. Sano, Y. Mizuno, S. Hoshino, M. Miyao, S. Inoue, K. Horiki, M. Shiraki, Y. Ouchi, H. Orimo, Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition 17(4), 315–321 (2001)
59. E. O’Connor, C. Molgaard, K.F. Michaelsen, J. Jakobsen, C.J. Lamberg-Allardt, K.D. Cashman, Serum percentage undercarboxylated osteocalcin, a sensitive measure of vitamin K status, and its relationship to bone health indices in Danish girls. Br. J. Nutr. 97(4), 661–666 (2007)
60. P. Szulc, M.C. Chapuy, P.J. Meunier, P.D. Delmas, Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J. Clin. Invest. 91(4), 1769–1774 (1993)
61. P. Szulc, P.D. Delmas, Influence of vitamin D and retinoids on the gammacarboxylation of osteocalcin in human osteosarcoma MG63 cells. Bone 19(6), 615–620 (1996)
62. P. Szulc, M. Arlot, M.C. Chapuy, F. Duboeuf, P.J. Meunier, P.D. Delmas, Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J. Bone Miner. Res. 9(10), 1591–1595 (1994)
63. L. Plantalech, M. Guillaumont, P. Vergnaud, M. Leclercq, P.D. Delmas, Impairment of gamma carboxylation of circulating osteocalcin (bone Gla protein) in elderly women. J. Bone Miner. Res. 6(11), 1211–1216 (1991)
64. M.H. Knapen, H.G. Eisenwiener, C. Vermeer, Osteocalcin detection in aging serum and whole blood: stability of different osteocalcin fractions. Clin. Chim. Acta 256(2), 151–164 (1996)
65. N. Furusyo, T. Ihara, T. Hayashi, H. Ikezaki, K. Toyoda, E. Ogawa, K. Okada, M. Kainuma, M. Murata, J. Hayashi, The serum undercarboxylated osteocalcin level and the diet of a Japanese population: results from the Kyushu and Okinawa Population Study (KOPS). Endocrine 43(3), 635–642 (2013)
66. P. Vergnaud, P. Garnero, P.J. Meunier, G. Bréart, K. Kamihagi, P.D. Delmas, Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J. Clin. Endocrinol. Metab. 82(3), 719–724 (1997)
67. T. Sugiyama, S. Kawai, Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J. Bone Miner. Metab. 19(3), 146–149 (2001)
68. V. Schwetz, T. Pieber, B. Obermayer-Pietsch, The endocrine role of the skeleton: background and clinical evidence. Eur. J. Endocrinol. 166(6), 959–967 (2012)
69. F. Oury, G. Sumara, O. Sumara, M. Ferron, H. Chang, C.E. Smith, L. Hermo, S. Suarez, B.L. Roth, P. Ducy, G. Karsenty, Endocrine regulation of male fertility by the skeleton. Cell 144(5), 796–809 (2011)
70. P. Wellendorph, H. Brauner-Osborne, Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene 335, 37–46 (2004)
71. P. Wellendorph, K.B. Hansen, A. Balsgaard, J.R. Greenwood, J. Egebjerg, H. Brauner-Osborne, Deorphanization of GPRC6A: a promiscuous l-alpha-amino acid receptor with preference for basic amino acids. Mol. Pharmacol. 67(3), 589–597 (2005)
72. F. Oury, L. Khrimian, C.A. Denny, A. Gardin, A. Chamouni, N. Goeden, Y.Y. Huang, H. Lee, P. Srinivas, X.B. Gao, S. Suyama, T. Langer, J.J. Mann, T.L. Horvath, A. Bonnin, G. Karsenty, Maternal and offspring pools of osteocalcin influence brain development and functions. Cell 155(1), 228–241 (2013)
73. S. Adami, Bone health in diabetes: considerations for clinical management. Curr. Med. Res. Opin. 25(5), 1057–1072 (2009)
74. J. Wei, M. Ferron, C.J. Clarke, Y.A. Hannun, H. Jiang, W.S. Blaner, G. Karsenty, Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J. Clin. Invest. 124(4), 1781–1793 (2014)
75. R.C. Riddle, T.L. Clemens, Insulin, osteoblasts, and energy metabolism: why bone counts calories. J. Clin. Invest. 124(4), 1465–1467 (2014)
76. M. Ferron, J. Wei, T. Yoshizawa, A. Del Fattore, R.A. DePinho, A. Teti, P. Ducy, G. Karsenty, Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142(2), 296–308 (2010)
77. J. Lacombe, G. Karsenty, M. Ferron, In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice. Mol. Metab. 2(4), 498–504 (2013)
78. M. Ferron, E. Hinoi, G. Karsenty, P. Ducy, Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. USA 105(13), 5266–5270 (2008)
79. J. Wei, T. Hanna, N. Suda, G. Karsenty, P. Ducy, Osteocalcin promotes beta-cell proliferation during development and adulthood through Gprc6a. Diabetes 63(3), 1021–1031 (2014)
80. K.J. Motyl, L.R. McCabe, A.V. Schwartz, Bone and glucose metabolism: a two-way street. Arch. Biochem. Biophys. 503(1), 2–10 (2010)
81. T. Yoshizawa, E. Hinoi, D.Y. Jung, D. Kajimura, M. Ferron, J. Seo, J.M. Graff, J.K. Kim, G. Karsenty, The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J. Clin. Invest. 119(9), 2807–2817 (2009)
82. M.T. Rached, A. Kode, B.C. Silva, D.Y. Jung, S. Gray, H. Ong, J.H. Paik, R.A. DePinho, J.K. Kim, G. Karsenty, S. Kousteni, FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J. Clin. Invest. 120(1), 357–368 (2010)
83. O. Johnell, W.H. Scheele, Y. Lu, J.Y. Reginster, A.G. Need, E. Seeman, Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis. J. Clin. Endocrinol. Metab. 87(3), 985–992 (2002)
84. M. Hirao, J. Hashimoto, W. Ando, T. Ono, H. Yoshikawa, Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women. J. Bone Miner. Metab. 26(3), 260–264 (2008)
85. H. Aonuma, N. Miyakoshi, M. Hongo, Y. Kasukawa, Y. Shimada, Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Tohoku J. Exp. Med. 218(3), 201–205 (2009)
86. A.L. Schafer, D.E. Sellmeyer, A.V. Schwartz, C.J. Rosen, E. Vittinghoff, L. Palermo, J.P. Bilezikian, D.M. Shoback, D.M. Black, Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1–84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J. Clin. Endocrinol. Metab. 96(12), E1982–E1989 (2011)
87. N. Bunyaratavej, Monitoring of Risedronate by biochemical bone markers in clinical practice. J. Med. Assoc. Thai. 88(suppl 5), S34–S36 (2005)
88. K. Suzuki, S. Tsuji, Y. Fukushima, T. Nakase, M. Hamada, T. Tomita, H. Yoshikawa, Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK(2)) in postmenopausal RA patients. Mod. Rheumatol. 23(3), 450–455 (2013)
89. M. Shiraki, Y. Yamazaki, Y. Shiraki, T. Hosoi, N. Tsugawa, T. Okano, High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment. J. Bone Miner. Metab. 28(5), 578–584 (2010)
90. P. Vestergaard, Risk of newly diagnosed type 2 diabetes is reduced in users of alendronate. Calcif. Tissue Int. 89(4), 265–270 (2011)
91. S. Dagdelen, D. Sener, M. Bayraktar, Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis. Adv. Ther. 24(6), 1314–1320 (2007)
92. T.C. Brennan-Speranza, H. Henneicke, S.J. Gasparini, K.I. Blankenstein, U. Heinevetter, V.C. Cogger, D. Svistounov, Y. Zhang, G.J. Cooney, F. Buttgereit, C.R. Dunstan, C. Gundberg, H. Zhou, M.J. Seibel, Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J. Clin. Invest. 122(11), 4172–4189 (2012)
93. C.B. Confavreux, R.L. Levine, G. Karsenty, A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol. Cell. Endocrinol. 310(1–2), 21–29 (2009)
94. J.M. Gimble, M.E. Nuttall, The relationship between adipose tissue and bone metabolism. Clin. Biochem. 45(12), 874–879 (2012)
95. J.F. Griffith, D.K. Yeung, G.E. Antonio, F.K. Lee, A.W. Hong, S.Y. Wong, E.M. Lau, P.C. Leung, Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology 236(3), 945–951 (2005)
96. F. Elefteriou, Regulation of bone remodeling by the central and peripheral nervous system. Arch. Biochem. Biophys. 473(2), 231–236 (2008)
97. T.A. Dardeno, S.H. Chou, H.S. Moon, J.P. Chamberland, C.G. Fiorenza, C.S. Mantzoros, Leptin in human physiology and therapeutics. Front. Neuroendocrinol. 31(3), 377–393 (2010)
98. P. Ducy, M. Amling, S. Takeda, M. Priemel, A.F. Schilling, F.T. Beil, J. Shen, C. Vinson, J.M. Rueger, G. Karsenty, Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100(2), 197–207 (2000)
99. S. Takeda, F. Elefteriou, R. Levasseur, X. Liu, L. Zhao, K.L. Parker, D. Armstrong, P. Ducy, G. Karsenty, Leptin regulates bone formation via the sympathetic nervous system. Cell 111(3), 305–317 (2002)
100. V.K. Yadav, F. Oury, N. Suda, Z.W. Liu, X.B. Gao, C. Confavreux, K.C. Klemenhagen, K.F. Tanaka, J.A. Gingrich, X.E. Guo, L.H. Tecott, J.J. Mann, R. Hen, T.L. Horvath, G. Karsenty, A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138(5), 976–989 (2009)
101. K.J. Motyl, C.J. Rosen, Understanding leptin-dependent regulation of skeletal homeostasis. Biochimie 94(10), 2089–2096 (2012)
102. H.S. Hill, J. Grams, R.G. Walton, J. Liu, D.R. Moellering, W.T. Garvey, Carboxylated and uncarboxylated forms of osteocalcin directly modulate the glucose transport system and inflammation in adipocytes. Horm. Metab. Res. 46(5), 341–347 (2014)
103. G. Lombardi, P. Lanteri, G. Graziani, A. Colombini, G. Banfi, R. Corsetti, Bone and energy metabolism parameters in professional cyclists during the Giro d’Italia 3-weeks stage race. PLoS ONE 7(7), e42077 (2012)
104. G. Karsenty, The mutual dependence between bone and gonads. J. Endocrinol. 213(2), 107–114 (2012)
105. B.V. Rosa, H.T. Blair, M.H. Vickers, C.G. Knight, P.C. Morel, E.C. Firth, Serum concentrations of fully and undercarboxylated osteocalcin do not vary between estrous cycle stages in Sprague-Dawley rats. Endocrine 44(3), 809–811 (2013)
106. M. Pi, L. Chen, M.Z. Huang, W. Zhu, B. Ringhofer, J. Luo, L. Christenson, B. Li, J. Zhang, P.D. Jackson, P. Faber, K.R. Brunden, J.J. Harrington, L.D. Quarles, GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS ONE 3(12), e3858 (2008)
107. G. Karsenty, F. Oury, Regulation of male fertility by the bone-derived hormone osteocalcin. Mol. Cell. Endocrinol. 382(1), 521–526 (2014)
108. B. Buday, F.P. Pach, B. Literati-Nagy, M. Vitai, Z. Vecsei, L. Koranyi, Serum osteocalcin is associated with improved metabolic state via adiponectin in females versus testosterone in males. Gender specific nature of the bone-energy homeostasis axis. Bone 57(1), 98–104 (2013)
109. F. Oury, M. Ferron, W. Huizhen, C. Confavreux, L. Xu, J. Lacombe, P. Srinivas, A. Chamouni, F. Lugani, H. Lejeune, T.R. Kumar, I. Plotton, G. Karsenty, Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J. Clin. Invest. 123(6), 2421–2433 (2013)
110. N.S. Datta, Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role? Endocrine (2014). doi:10.1007/s12020-014-0273-3
111. I. Levinger, D. Scott, G.C. Nicholson, A.L. Stuart, G. Duque, T. McCorquodale, M. Herrmann, P.R. Ebeling, K.M. Sanders, Undercarboxylated osteocalcin, muscle strength and indices of bone health in older women. Bone 64, 8–12 (2014)
112. S.K. Mishra, V. Misra, Muscle sarcopenia: an overview. Acta Myol. 22(2), 43–47 (2003)
113. L.A. Schaap, S.M. Pluijm, D.J. Deeg, M. Visser, Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am. J. Med. 119(6), 526.e9–526.e17 (2006)
114. I. Levinger, R. Zebaze, G. Jerums, D.L. Hare, S. Selig, E. Seeman, The effect of acute exercise on undercarboxylated osteocalcin in obese men. Osteoporos. Int. 22(5), 1621–1626 (2011)
115. Y. Rolland, G. Onder, J.E. Morley, S. Gillette-Guyonet, G. Abellan van Kan, B. Vellas, Current and future pharmacologic treatment of sarcopenia. Clin. Geriatr. Med. 27(3), 423–447 (2011)
116. J.M. Fernandez-Real, M. Izquierdo, F. Ortega, E. Gorostiaga, J. Gomez-Ambrosi, J.M. Moreno-Navarrete, G. Fruhbeck, C. Martinez, F. Idoate, J. Salvador, L. Forga, W. Ricart, J. Ibanez, The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J. Clin. Endocrinol. Metab. 94(1), 237–245 (2009)
117. J. Li, A.J. Flammer, R.E. Nelson, R. Gulati, P.A. Friedman, R.J. Thomas, N.P. Sandhu, M.K. Reriani, L.O. Lerman, A. Lerman, Normal vascular function as a prerequisite for the absence of coronary calcification in patients free of cardiovascular disease and diabetes. Circ. J. 76(11), 2705–2710 (2012)
118. D. Yamanouchi, Y. Takei, K. Komori, Balanced mineralization in the arterial system: possible role of osteoclastogenesis/osteoblastogenesis in abdominal aortic aneurysm and stenotic disease. Circ. J. 76(12), 2732–2737 (2012)
119. A. Heiss, T. Eckert, A. Aretz, W. Richtering, W. van Dorp, C. Schafer, W. Jahnen-Dechent, Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J. Biol. Chem. 283(21), 14815–14825 (2008)
120. E. Theuwissen, E. Smit, C. Vermeer, The role of vitamin K in soft-tissue calcification. Adv. Nutr. 3(2), 166–173 (2012)
121. J. Hjortnaes, S.E. New, E. Aikawa, Visualizing novel concepts of cardiovascular calcification. Trends Cardiovasc. Med. 23(3), 71–79 (2013)
122. B.F. Stewart, D. Siscovick, B.K. Lind, J.M. Gardin, J.S. Gottdiener, V.E. Smith, D.W. Kitzman, C.M. Otto, Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29(3), 630–634 (1997)
123. C. Schafer, A. Heiss, A. Schwarz, R. Westenfeld, M. Ketteler, J. Floege, W. Muller-Esterl, T. Schinke, W. Jahnen-Dechent, The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 112(3), 357–366 (2003)
124. E. Aikawa, M. Nahrendorf, D. Sosnovik, V.M. Lok, F.A. Jaffer, M. Aikawa, R. Weissleder, Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 115(3), 377–386 (2007)
125. P.G. van de Loo, B.A. Soute, L.J. van Haarlem, C. Vermeer, The effect of Gla-containing proteins on the precipitation of insoluble salts. Biochem. Biophys. Res. Commun. 142(1), 113–119 (1987)
126. P.A. Price, D. Toroian, J.E. Lim, Mineralization by inhibitor exclusion: the calcification of collagen with fetuin. J. Biol. Chem. 284(25), 17092–17101 (2009)
127. L.J. Schurgers, H. Aebert, C. Vermeer, B. Bultmann, J. Janzen, Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood 104(10), 3231–3232 (2004)
128. R. Koos, A.H. Mahnken, G. Muhlenbruch, V. Brandenburg, B. Pflueger, J.E. Wildberger, H.P. Kuhl, Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am. J. Cardiol. 96(6), 747–749 (2005)
129. M. Hristova, C. van Beek, L.J. Schurgers, B. Lanske, J. Danziger, Rapidly progressive severe vascular calcification sparing the kidney allograft following warfarin initiation. Am. J. Kidney Dis. 56(6), 1158–1162 (2010)
130. R.J. Rennenberg, B.J. van Varik, L.J. Schurgers, K. Hamulyak, H. Ten Cate, T. Leiner, C. Vermeer, P.W. de Leeuw, A.A. Kroon, Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood 115(24), 5121–5123 (2010)
131. B. Weijs, Y. Blaauw, R.J. Rennenberg, L.J. Schurgers, C.C. Timmermans, L. Pison, R. Nieuwlaat, L. Hofstra, A.A. Kroon, J. Wildberger, H.J. Crijns, Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur. Heart J. 32(20), 2555–2562 (2011)
132. C.M. Gundberg, J.B. Lian, S.L. Booth, Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv. Nutr. 3(2), 149–157 (2012)